Viridian Therapeutics, Inc.\DE

VRDN·NASDAQ·$17.00Share Price as of 11/2·$2BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/05/26 10-KFY 202502/26/26 10-QQ3 ended 09/30/2511/05/25 10-QQ2 ended 06/30/2508/06/25

Disclosures

8-KCurrent report08/06/26 8-KCurrent report06/29/26 8-KCurrent report06/03/26 8-KCurrent report05/28/26 8-KCurrent report05/26/26

Prospectuses and Registrations

424B5Prospectus supplement05/08/26 424B5Prospectus supplement05/08/26 FWPFree writing prospectus05/07/26 FWPFree writing prospectus05/07/26 424B5Prospectus supplement05/06/26

Proxies

DEF 14ADefinitive proxy04/17/26 DEFA14AAdditional proxy materials04/17/26 DEF 14ADefinitive proxy04/25/25 DEFA14AAdditional proxy materials04/25/25 DEFA14AAdditional proxy materials06/10/24

Ownership

Form 4Insider transaction08/20/26 SC 13GBeneficial ownership08/20/26 144Proposed sale of securities08/19/26 Form 4Insider transaction08/18/26 SC 13GBeneficial ownership08/14/26

Other

305B2305B205/07/26 ARSAnnual report to shareholders04/17/26 ARSAnnual report to shareholders04/25/25 ARSAnnual report to shareholders04/26/24 ARSAnnual report to shareholders04/28/23